REGADENOSON (REGADENOSON) — FDA Approval ANDA213856 (MYLAN)
REGADENOSON (REGADENOSON) — FDA Approval ANDA213856 (MYLAN) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: REGADENOSON; Active ingredients: REGADENOSON; Application number: ANDA213856.
| Brand name | REGADENOSON |
|---|---|
| Active ingredients | REGADENOSON |
| Application number | ANDA213856 |
| Sponsor | MYLAN |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20230404 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →